Filtros de búsqueda

Lista de obras de Philippe Billiald

A method to confer Protein L binding ability to any antibody fragment

artículo científico publicado en 2015

A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector.

artículo científico publicado en 1999

Antibody Fragments Humanization: Beginning with the End in Mind

artículo científico publicado en 2019

Approach to the direct intramolecular localization of antigenic determinants in Androctonus australis hemocyanin with monoclonal antibodies by molecular immunoelectron microscopy.

artículo científico publicado en 1985

Biomolecular engineering of antidehydroepiandrosterone antibodies: a new perspective in cancer diagnosis and treatment using single-chain antibody variable fragment

scientific article published on 29 January 2019

Colorimetric engineered immunoprobe for the detection and quantification of microcystins.

artículo científico publicado en 2014

Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector.

artículo científico publicado en 2001

Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies.

artículo científico publicado en 2013

Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin.

artículo científico publicado en 2003

Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro

artículo científico publicado en 2009

Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential

artículo científico publicado en 2011

Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks

artículo científico publicado en 2017

Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom.

artículo científico publicado en 2012

Engineering venom's toxin-neutralizing antibody fragments and its therapeutic potential

artículo científico publicado en 2014

Envenomations VI. Scorpionism in Africa

artículo científico

Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease.

artículo científico publicado en 2016

Generation of recombinant antibody fragments with toxin-neutralizing potential in loxoscelism.

artículo científico publicado en 2016

Grafting of protein L-binding activity onto recombinant antibody fragments

artículo científico publicado en 2009

Immunodetection of the "brown" spider (Loxosceles intermedia) dermonecrotoxin with an scFv-alkaline phosphatase fusion protein

artículo científico publicado en 2016

Immunolabeling of CD3-positive lymphocytes with a recombinant single-chain antibody/alkaline phosphatase conjugate.

artículo científico publicado en 2000

Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential

scientific article published on 16 April 2020

Mapping of six epitopes on haemocyanin subunit Aa 6 by immunoelectron microscopy

artículo científico publicado en 1988

Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI

artículo científico publicado en 2009

PCR: principles and prospects in clinical biology

artículo científico publicado en 1995

Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet Aggregation

scientific article published on 04 June 2020

Production of a functional anti-scorpion hemocyanin scFv in Escherichia coli

scientific article published on 01 March 1995

Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development.

artículo científico publicado en 2018

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab

scientific article published on 01 May 2019

The future of glycoprotein VI as an antithrombotic target.

artículo científico

Using a recombinant bispecific antibody to block Na+ -channel toxins protects against experimental scorpion envenoming.

artículo científico

[Antithrombotic recombinant antibodies]

scientific article published on 01 January 2006

[Recombinant antibodies: towards a new generation of antivenoms?]

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda